Enteral Nutrition After Pancreaticoduodenectomy
- Conditions
- Cancer of DuodenumCancer of PancreasCholangiocarcinomaAmpulla of Vater Cancer
- Interventions
- Other: SalineOther: Early enteral nutritionDevice: nasojejunal tube insertionOther: Oral intake
- Registration Number
- NCT03150615
- Lead Sponsor
- Nanjing Medical University
- Brief Summary
Pancreaticoduodenectomy (PD) is the treatment of choice for resectable periampullary cancer. PD is still associated with a relatively a high incidence of delayed gastric emptying. And, there are no acknowledged strategies to avoid DGE. Several feeding strategies have been investigated to cope with this problem. However, there is still no consensus concerning the best nutrition support method after pancreaticoduodenectomy. The purpose of this study is to determine the effect of nutrition support methods on DGE after pancreaticoduodenectomy: early enteral nutrition or total parenteral nutrition.
Patients undergoing pancreatoduodenectomy will be randomized to receive early enteral nutrition (EN group), or Saline administration (Saline group), or oral intake only (Natural control). The EN group will receive standard enteral diet administered through a nasojejunal tube. Enteral nutrition will be started on the 1st postoperative day and increased daily by 20-40 ml up to the estimated level. The Saline group will receive saline administered through a nasojejunal tube beginning from the 1st postoperative day. Oral intake will not be restricted in all three group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
Patients underwent selective pancreaticoduodenectomy Patients ≥18 years old and ≤80 years old Having given written informed consent
Previous gastric resection or intestinal reconstruction Preoperative complete parenteral or enteral feeding ASA score ≥4 Pregnant women Severe malnutrition Patient who cannot give written informed consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Early enteral nutrition Oral intake Nasojejunal tube insertion was done intraopratively. Early enteral nutrition with standard enteral formulas administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate. Saline Group nasojejunal tube insertion Nasojejunal tube insertion was done intraopratively. Saline was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate. Saline Group Saline Nasojejunal tube insertion was done intraopratively. Saline was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate. Early enteral nutrition nasojejunal tube insertion Nasojejunal tube insertion was done intraopratively. Early enteral nutrition with standard enteral formulas administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate. ERAS Group nasojejunal tube insertion Nasojejunal tube insertion was done intraopratively. None was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate. ERAS Group Oral intake Nasojejunal tube insertion was done intraopratively. None was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate. Early enteral nutrition Early enteral nutrition Nasojejunal tube insertion was done intraopratively. Early enteral nutrition with standard enteral formulas administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.
- Primary Outcome Measures
Name Time Method Incident rate of delayed gastric emptying 30 days DGE represents the inability to return to a standard diet by the end of the first postoperative week and includes prolonged nasogastric intubation of the patient. Three different grades (A,B,and C) were defined based on the impact on the clinical course and on postoperative management by ISGPS.
- Secondary Outcome Measures
Name Time Method Pancreatic fistulas 30 days evaluation of the occurrence of pancreatic fistulas, grade B and C, in both groups of patients
Maximum Plasma Concentration fasting plasma GLP-1 level Preoperative day 1, Postoperative day 1, Postoperative day 4, Postoperative day 7 Fasting plasma concentration GLP-1 level was monitored
Infectious complications 30 days Postoperative mortality rate 30 days Overall morbidity rate 30 days Rehospitalization rate 60 days Postoperative hospital stay length 60 days Evaluation of the severity of the complications 30 days according to classification of Dindo-Clavien
Hemorrhagic complications 30 days evaluation of the occurrence of hemorrhagic complications, grade B and C, in both groups of patients
Trial Locations
- Locations (1)
The first affiliated hospital of Nanjing Medical University
🇨🇳Nanjing, Jiangsu, China